Dr Reddys Laboratories Ltd
RDY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001135951
No open-market purchases or sales by Dr Reddys Laboratories Ltd insiders were filed in the last 90 days; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.82B in total; no superinvestor holds it.
Holders of 5% or more of RDY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Dr Reddys Laboratories Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Prasad G V | 13D/A | 13.58%113.4M shares | – | Sep 18, 20251 filing | Sep 18, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Dr Reddys Laboratories Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 18, 202511:43 AM ET | Prasad G Vand 5 others | 13D/A | 13.58%113.4M shares | – | Sep 17, 2025 | SEC |
| Apr 28, 20259:11 PM ET | BlackRock, Inc. | 13G/A | 4.10%34.5M shares | –Below 5% | Mar 31, 2025 | SEC |
| May 2, 2022 | Dr. Reddy's Holdings Ltd | 13D/AOld format | – | – | – | SEC |
| Feb 2, 20217:05 AM ET | Mitsubishi Ufj Financial Group Inc | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Dr Reddys Laboratories Ltd shares.
No Form 144 notices for Dr Reddys Laboratories Ltd are on file.